High expression of RAD18 in glioma induces radiotherapy resistance via down-regulating P53 expression
Open Access
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 112, 108555
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathwayCancer Letters, 2018
- Changing incidence and improved survival of gliomasEuropean Journal of Cancer, 2014
- RAD18 mediates resistance to ionizing radiation in human glioma cellsBiochemical and Biophysical Research Communications, 2014
- Biological Relevance of DNA Polymerase Beta and Translesion Synthesis Polymerases to Cancer and its TreatmentCurrent Molecular Pharmacology, 2012
- Targeted Therapies for Malignant GliomaBioDrugs, 2009
- Role of DNA polymerases η, ι and ζ in UV resistance and UV-induced mutagenesis in a human cell lineDNA Repair, 2008
- Down-regulation of DNA polymerases κ, η, ι, and ζ in human lung, stomach, and colorectal cancersCancer Letters, 2005
- The human RAD18 gene product interacts with HHR6A and HHR6BNucleic Acids Research, 2000
- Dysfunction of human Rad18 results in defective postreplication repair and hypersensitivity to multiple mutagensProceedings of the National Academy of Sciences, 2000
- Specific complex formation between yeast RAD6 and RAD18 proteins: a potential mechanism for targeting RAD6 ubiquitin-conjugating activity to DNA damage sites.Genes & Development, 1994